Fennec Pharmaceuticals (FENC) Amortization - Deferred Charges: 2011-2025
Historic Amortization - Deferred Charges for Fennec Pharmaceuticals (FENC) over the last 6 years, with Sep 2025 value amounting to $12,000.
- Fennec Pharmaceuticals' Amortization - Deferred Charges fell 42.86% to $12,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $63,000, marking a year-over-year decrease of 52.99%. This contributed to the annual value of $89,000 for FY2024, which is 68.99% down from last year.
- Fennec Pharmaceuticals' Amortization - Deferred Charges amounted to $12,000 in Q3 2025, which was down 7.69% from $13,000 recorded in Q2 2025.
- Over the past 5 years, Fennec Pharmaceuticals' Amortization - Deferred Charges peaked at $141,000 during Q4 2022, and registered a low of $7,000 during Q1 2022.
- Its 3-year average for Amortization - Deferred Charges is $37,636, with a median of $23,000 in 2024.
- In the last 5 years, Fennec Pharmaceuticals' Amortization - Deferred Charges tumbled by 97.75% in 2021 and then surged by 928.57% in 2023.
- Fennec Pharmaceuticals' Amortization - Deferred Charges (Quarterly) stood at $8,000 in 2021, then spiked by 700.00% to $141,000 in 2022, then slumped by 50.35% to $70,000 in 2023, then crashed by 64.29% to $25,000 in 2024, then crashed by 42.86% to $12,000 in 2025.
- Its Amortization - Deferred Charges stands at $12,000 for Q3 2025, versus $13,000 for Q2 2025 and $13,000 for Q1 2025.